Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting obvious toxicity in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 239.00 | |
10 mg | In stock | $ 356.00 | |
25 mg | In stock | $ 588.00 | |
50 mg | In stock | $ 857.00 | |
100 mg | In stock | $ 1,180.00 | |
500 mg | In stock | $ 2,360.00 |
Description | CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting obvious toxicity in vivo. |
Synonyms | CHMFLFLT3122, CHMFL FLT3 122 |
Molecular Weight | 471.55 |
Formula | C26H29N7O2 |
CAS No. | 1839150-56-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1eq. HCl: 90.0 mg/mL (190.9 mM)
DMSO: 90.0 mg/mL (190.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CHMFL-FLT3-122 1839150-56-9 Angiogenesis Tyrosine Kinase/Adaptors FLT CHMFLFLT-3122 CHMFLFLT3122 CHMFL FLT3 122 CHMFLFLT 3122 inhibitor inhibit